{"id":"W2109157463","doi":"10.2337/diabetes.54.10.2988","title":"Dipeptidyl Peptidase IV Inhibition for the Treatment of Type 2 Diabetes","year":2005,"lang":"en","type":"article","venue":"Diabetes","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":491,"is_retracted":false,"has_abstract":true,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Dipeptidyl peptidase; Incretin; Dipeptidyl peptidase-4; Internal medicine; Dipeptidase; Toxicity; Endocrinology; Tolerability; Type 2 diabetes; Diabetes mellitus; Pharmacology; Medicine; Biology; Enzyme; Adverse effect; Biochemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001121738,0.0001562326,0.0003119138,0.0001070836,0.0001005091,0.0000162644,0.00004040477,0.00006187658,0.0003846419],"category_scores_gemma":[0.00007756846,0.00009721193,0.0002926961,0.0002305727,0.0001041248,0.00007253652,0.000008601814,0.00004462553,0.00007074531],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000685249,"about_ca_system_score_gemma":0.00003126013,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004034509,"about_ca_topic_score_gemma":0.00000516199,"domain_scores_codex":[0.9990962,0.00002165669,0.0002678401,0.0001905364,0.000162208,0.0002615378],"domain_scores_gemma":[0.9991106,0.0002532264,0.00009684388,0.0002824848,0.0001661554,0.00009070156],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001690656,0.003125839,0.06274619,0.0003206872,0.001113932,0.000003515565,0.001142672,0.000174503,0.7684624,0.0007123119,0.01681636,0.1452126],"study_design_scores_gemma":[0.003044604,0.00173771,0.008466638,0.0003688116,0.0006570311,7.486537e-7,0.0002141271,0.01026982,0.9144899,0.0001758163,0.06034912,0.000225647],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947993,0.00100849,0.00002826517,0.003006469,0.0000300017,0.0004150803,0.00006091543,0.00005334408,0.0005981998],"genre_scores_gemma":[0.9965042,0.0001429192,0.0004879786,0.000797842,0.0004402614,0.0001158827,0.0001966115,0.00002060858,0.001293717],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1460276,"threshold_uncertainty_score":0.421156,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01898075038402413,"score_gpt":0.2728764479038947,"score_spread":0.2538956975198706,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}